Taxifolin 7-rhamnoside

Catalog No.S3295 Synonyms: TR, Taxifolin 7-O-rhamnoside, Taxifolin 7-O-α-L-rhamnoside

For research use only.

Taxifolin 7-rhamnoside (TR, Taxifolin 7-O-rhamnoside, Taxifolin 7-O-α-L-rhamnoside), a flavonoid isolated from Hypericum japonicum, shows antibacterial activity against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).

Taxifolin 7-rhamnoside Chemical Structure

CAS No. 137592-12-2

Purity & Quality Control

Choose Selective Bacterial Inhibitors

Biological Activity

Description Taxifolin 7-rhamnoside (TR, Taxifolin 7-O-rhamnoside, Taxifolin 7-O-α-L-rhamnoside), a flavonoid isolated from Hypericum japonicum, shows antibacterial activity against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).

Protocol (from reference)

Solubility (25°C)

In vitro

Chemical Information

Molecular Weight 450.39
Formula

C21H22O11

CAS No. 137592-12-2
Storage 3 years -20°C powder
2 years -80°C in solvent

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT05436028 Not yet recruiting Device: Transcatheter Tricuspid Valve Intervention Tricuspid Regurgitation Jenscare Scientific December 2022 Not Applicable
NCT05440942 Not yet recruiting Drug: Trametinib|Drug: Ruxolitinib|Drug: Retifanlimab Pancreatic Ductal Adenocarcinoma Peter Hosein MD|Incyte Corporation|Novartis Pharmaceuticals|University of Miami Sylvester Comprehensive Cancer Center|University of Miami October 2022 Phase 1
NCT04100720 Not yet recruiting Device: Cardiovalve Transfemoral Tricuspid Valve Tricuspid Regurgitation Boston Biomedical Associates|Cardiovalve Ltd.|Cardiovascular Research Foundation New York October 2022 Not Applicable
NCT05414513 Not yet recruiting -- Chronic Headache Akdeniz University September 8 2022 --

(data from https://clinicaltrials.gov, updated on 2022-08-01)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Taxifolin 7-rhamnoside | Taxifolin 7-rhamnoside supplier | purchase Taxifolin 7-rhamnoside | Taxifolin 7-rhamnoside cost | Taxifolin 7-rhamnoside manufacturer | order Taxifolin 7-rhamnoside | Taxifolin 7-rhamnoside distributor